Friday, February 8, 2013

Insight: GSK vaccine ingredient scrutinized for narcolepsy clues

File photo of a nurse holding a bottle of the Pandemrix H1N1 flu vaccine and a bottle of the vaccine's adjuvant at a health centre in BurgosLONDON (Reuters) - Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients, AS03, under intense scrutiny. The ingredient is one of a class of pharmaceuticals known as adjuvants, or boosters, designed to turbo charge the potency of a vaccine and the body's immune response to it. ...


Get the complete story

No comments:

Post a Comment